J.P. Morgan Private Wealth Advisors LLC - NEKTAR THERAPEUTICS ownership

NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 383 filers reported holding NEKTAR THERAPEUTICS in Q2 2018. The put-call ratio across all filers is 0.42 and the average weighting 0.1%.

Quarter-by-quarter ownership
J.P. Morgan Private Wealth Advisors LLC ownership history of NEKTAR THERAPEUTICS
ValueSharesWeighting
Q2 2021$187,000
-15.8%
10,892
-1.9%
0.00%
-100.0%
Q1 2021$222,000
+12.7%
11,107
-4.2%
0.00%0.0%
Q4 2020$197,000
-17.2%
11,589
-19.1%
0.00%0.0%
Q3 2020$238,000
-27.2%
14,331
+1.4%
0.00%0.0%
Q2 2020$327,000
+26.3%
14,140
-2.7%
0.00%0.0%
Q1 2020$259,000
+4.9%
14,537
+27.1%
0.00%0.0%
Q4 2019$247,000
+0.8%
11,434
-15.0%
0.00%0.0%
Q3 2019$245,000
-52.3%
13,453
-6.9%
0.00%
-66.7%
Q2 2019$514,000
+6.9%
14,453
+0.9%
0.00%0.0%
Q1 2019$481,000
+4.1%
14,322
+1.8%
0.00%0.0%
Q4 2018$462,000
-56.0%
14,070
-18.4%
0.00%
-40.0%
Q3 2018$1,051,000
+37.7%
17,234
+10.3%
0.01%
+25.0%
Q2 2018$763,000
-45.1%
15,622
+19.3%
0.00%
-55.6%
Q1 2018$1,391,000
+10.4%
13,093
-37.9%
0.01%
+12.5%
Q4 2017$1,260,000
+103.2%
21,091
-18.5%
0.01%
+100.0%
Q3 2017$620,000
+51.6%
25,864
+23.6%
0.00%
+33.3%
Q2 2017$409,000
-7.5%
20,926
+11.1%
0.00%0.0%
Q1 2017$442,000
+187.0%
18,840
+74.2%
0.00%
+200.0%
Q2 2016$154,00010,8140.00%
Other shareholders
NEKTAR THERAPEUTICS shareholders Q2 2018
NameSharesValueWeighting ↓
Ally Bridge Group (NY) LLC 432,952$1,385,0000.91%
GREAT POINT PARTNERS LLC 447,820$1,433,0000.34%
Birchview Capital, LP 128,000$410,0000.29%
Edgestream Partners, L.P. 1,047,636$3,352,0000.26%
Rhenman & Partners Asset Management AB 550,000$2,068,0000.22%
CM Management, LLC 50,000$160,0000.18%
TANG CAPITAL MANAGEMENT LLC 430,037$1,376,0000.17%
PDT Partners, LLC 307,953$985,0000.15%
Virtus ETF Advisers LLC 72,018$230,0000.09%
ALGERT GLOBAL LLC 476,412$1,525,0000.09%
View complete list of NEKTAR THERAPEUTICS shareholders